Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t(5;12)(q33;p13.1) without eosinophilia

Cancer Genetics and Cytogenetics

Volumn 169, Issue 2, 2006, Pages 174-175

  Nadal, Nathalie ^a   Flandrin, Pascale ^a   Cornillon, Jerome ^a   Delabesse, Eric ^b   Mauvieux, Laurent ^c   Olaru, Daniela ^a   Morel, Sylvie ^a   Campos, Lydia ^a  

^a HÔPITAL NORD   (France)

^b Laboratoire Central d'Hematologie   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; ANAMNESIS; CASE REPORT; CHROMOSOME 13P; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 5; CHRONIC DISEASE; EOSINOPHILIA; HUMAN; HUMAN CELL; LABORATORY TEST; LETTER; MALE; MYELOPROLIFERATIVE DISORDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 5; CHRONIC DISEASE; EOSINOPHILIA; HUMANS; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PIPERAZINES; PYRIMIDINES; TRANSLOCATION, GENETIC;

EID: 33747818613     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.02.014     Document Type: Letter

References (7)

1. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
2. Pellier I., Le Moine P.J., Rialland X., Francois S., Baranger L., Blanchet O., Larget-Piet L., and Ifrah N. Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literature. J Pediatr Hematol Oncol 18 (1996) 285-288
3. Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S., Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M., and Hirashima K. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13). Genes Chromosomes Cancer 26 (1999) 192-202
4. Carroll M., Ohno-Jones S., Tamura S., Buchdunger E., Zimmermann J., Lydon N.B., Gilliland D.G., and Druker B.J. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 90 (1997) 4947-4952
5. Apperley J.F., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J., Baxter E.J., Chase A., Chessells J.M., Colombat M., Dearden C.E., Dimitrijevic S., Mahon F.X., Marin D., Nikolova Z., Olavarria E., Silberman S., Schultheis B., Cross N.C., and Goldman J.M. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 347 (2002) 481-487
6. Pitini V., Arrigo C., Teti D., Barresi G., Righi M., and Alo G. Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report. Haematologica 88 (2003) ECR18
7. Wittman B., Horan J., Baxter J., Goldberg J., Felgar R., Baylor E., Cromwell B., Cross N., and Bennett J.M. A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate. Leuk Res 28 Suppl 1 (2004) S65-S69